跳至主要内容
临床试验/IRCT20200822048473N1
IRCT20200822048473N1招募中3 期

The effect of fenofibrate on the prevention of neonatal hyperbilirubinemia in mothers with O type blood group

Babol University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 28 days(—)
性别
All

入选标准

  • Term neonatal (37 weeks to 41 weeks and 6 days)
  • Neonatal with blood type A or B from mothers with positive O blood type and fathers with A, B or AB blood types
  • Without congenital anomalies, birth trauma and history of resuscitation at birth
  • Neonatal born by elective cesarean section who did not receive induction before delivery
  • Rh incompatibility

排除标准

  • 未提供

研究者

相似试验

The effect of fenofibrate on the prevention of... | 临床试验